Clinical Application Research of WILLIS® Obtained the First Class Award in Science and Technology Progress
On May 18th, the clinical application of CEREBRAL aneurysms its related vascular MRA imaging and key technologies of interventional treatment, which based on clinical research of WILLIS® intracranial graft stent obtained the First Class Award of Science and Technology Progress issued by the Ministry of Education. MicroPort, as one of the co-sponsors for the research project, won the award together with Shanghai Sixth People's Hospital.
WILLIS® intracranial stent is the first graft stent product that is indicated for the treatment of intracranial aneurysms. WILLIS® intracranial graft stent can isolate and make occlusion of the aneurysm, as well as reserve the aneurysm artery patency and restore normal blood flow in the lesions area. WILLIS® clinical trials have successfully achieved its research hypothesis: six months' total occlusive ratio of aneurysm was superior to the method of coil embolization.
This website may store cookies on your browser. Cookies are mostly used to make the website work as you expect it to. No cookie will directly identify you, but it can give you a more personalized browsing experience.
MicroPort respects your privacy rights, so you can block some types of cookies. Technically non-essential cookies and tracking mechanisms, that enable us to provide you with customized offers (marketing cookies), are only used if you have given prior consent to such use.
By clicking “Save”, only the cookies you selected will be used. You can withdraw the consent that you granted here at any time by going to Cookies Settings.